These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Sajid M; McKerrow JH; Hansell E; Mathieu MA; Lucas KD; Hsieh I; Greenbaum D; Bogyo M; Salter JP; Lim KC; Franklin C; Kim JH; Caffrey CR Mol Biochem Parasitol; 2003 Sep; 131(1):65-75. PubMed ID: 12967713 [TBL] [Abstract][Full Text] [Related]
8. Prospects for Vector-Based Gene Silencing to Explore Immunobiological Features of Schistosoma mansoni. Hagen J; Scheerlinck JP; Young ND; Gasser RB; Kalinna BH Adv Parasitol; 2015 Apr; 88():85-122. PubMed ID: 25911366 [TBL] [Abstract][Full Text] [Related]
9. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice. Perera DJ; Hassan AS; Liu SS; Elahi SM; Gadoury C; Weeratna RD; Gilbert R; Ndao M EBioMedicine; 2022 Jun; 80():104036. PubMed ID: 35500538 [TBL] [Abstract][Full Text] [Related]
10. Integration of reporter transgenes into Schistosoma mansoni chromosomes mediated by pseudotyped murine leukemia virus. Kines KJ; Morales ME; Mann VH; Gobert GN; Brindley PJ FASEB J; 2008 Aug; 22(8):2936-48. PubMed ID: 18403630 [TBL] [Abstract][Full Text] [Related]
11. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Skelly PJ; Da'dara A; Harn DA Int J Parasitol; 2003 Apr; 33(4):363-9. PubMed ID: 12705930 [TBL] [Abstract][Full Text] [Related]
12. Dual Strategy to Design New Agents Targeting Fuchs N; Zimmermann RA; Schwickert M; Gunkel A; Zimmer C; Meta M; Schwickert K; Keiser J; Haeberli C; Kiefer W; Schirmeister T ACS Infect Dis; 2024 May; 10(5):1664-1678. PubMed ID: 38686397 [TBL] [Abstract][Full Text] [Related]
13. Methods for Studying the Germline of the Human Parasite Schistosoma mansoni. Collins JN; Collins JJ Methods Mol Biol; 2017; 1463():35-47. PubMed ID: 27734345 [TBL] [Abstract][Full Text] [Related]
14. Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells. Duvoisin R; Ayuk MA; Rinaldi G; Suttiprapa S; Mann VH; Lee CM; Harris N; Brindley PJ Transgenic Res; 2012 Jun; 21(3):511-21. PubMed ID: 21953124 [TBL] [Abstract][Full Text] [Related]
15. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase. Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516 [TBL] [Abstract][Full Text] [Related]
17. RNA interference in vivo in Schistosoma japonicum: Establishing and optimization of RNAi mediated suppression of gene expression by long dsRNA in the intra-mammalian life stages of worms. Li J; Xiang M; Zhang R; Xu B; Hu W Biochem Biophys Res Commun; 2018 Sep; 503(2):1004-1010. PubMed ID: 29935182 [TBL] [Abstract][Full Text] [Related]
18. Recombinant expression and localization of Schistosoma mansoni cathepsin L1 support its role in the degradation of host hemoglobin. Brady CP; Dowd AJ; Brindley PJ; Ryan T; Day SR; Dalton JP Infect Immun; 1999 Jan; 67(1):368-74. PubMed ID: 9864238 [TBL] [Abstract][Full Text] [Related]